Saint John's Cancer Institute

Research Output

Research output per year 1968 2004 2006 2011 2012 2013 2014 2015 2017 2018 2019 2020 2021 2022 2025

• 154253 Citations
• 1724 Article
• 196 Review article
• 88 Comment/debate
• 70 Other contribution
• 168 More
  • 67 Chapter
  • 37 Letter
  • 16 Editorial
  • 15 Abstract
  • 12 Conference contribution
  • 10 Short survey
  • 6 Poster
  • 2 Book
  • 2 Conference article
  • 1 Foreword/postscript

Research output per year

Research output per year

Search results

• 2025

  Cushing's Disease Clinical Phenotype and Tumor Behavior Vary with Age: Diagnostic and Perioperative Implications.

  Salcedo-Sifuentes, J. E., Shih, R., Heaney, A. P., Bergsneider, M., Wang, M. B., Donangelo, I., Lee, J., Delery, W., Karsy, M., Kshettry, V. R., Yuen, K. C. J., Evans, J. J., Barkhoudarian, G., Pacione, D. R., Gardner, P. A., Fernandez-Miranda, J. C., Benjamin, C., Zada, G., Rennert, R. C. & Silverstein, J. M. & 5 others, Chicoine, M. R., Kim, J., Li, G., Little, A. S. & Kim, W., Jan 2 2025, In: The Journal of clinical endocrinology and metabolism.

  Research output: Contribution to journal › Article

• Highlights and Perspectives from the Society of Surgical Oncology’s Statements on Bilateral and Contralateral Risk-Reducing Mastectomy

  Society of Surgical Oncology Breast Disease Site Work Group, Jun 2025, In: Annals of Surgical Oncology. 32, 6, p. 3857-3860 4 p.

  Research output: Contribution to journal › Editorial

• Indications and outcomes of the extended endoscopic endonasal approach for the removal of "unconventional" suprasellar pituitary neuroendocrine tumors.

  Solari, D., d'Avella, E., Barkhoudarian, G., Zoli, M., Cheok, S., Bove, I., Fabozzi, G. L., Zada, G., Mazzatenta, D., Kelly, D. F., Cappabianca, P. & Cavallo, L. M., Mar 28 2025, In: Journal of neurosurgery.

  Research output: Contribution to journal › Article

• Longitudinal retrospective study of real-world adherence to colorectal cancer screening before and after the COVID-19 pandemic in the USA.

  Gupta, H., Husa, R. A., Wendt, S. J., Vita, A., Boone, C., Weiss, J. B. & Bilchik, A. J., Jan 1 2025, In: BMJ Public Health.

  Research output: Contribution to journal › Article
• 2024

  Acupuncture for Chronic Radiation-Induced Xerostomia in Head and Neck Cancer: A Multicenter Randomized Clinical Trial

  Cohen, L., Danhauer, S. C., Garcia, M. K., Dressler, E. V., Rosenthal, D. I., Chambers, M. S., Cusimano, A., Brown, W. M., Ochoa, J. M., Yang, P., Chiang, J. S., Gordon, O., Crutcher, R., Kim, J. K., Russin, M. P., Lukenbill, J., Porosnicu, M., Yost, K. J., Weaver, K. E. & Lesser, G. J., 2024, (Accepted/In press) In: JAMA Network Open. p. E2410421

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Randomized Clinical Trial 100%
  • Head and Neck Cancer 100%
  • Xerostomia 100%
  • Acupuncture 100%
  • Oral Hygiene 42%
  8 Scopus citations

• American Association of Neurological Surgeons/Congress of the Neurological Surgeons Section on Tumors Guidelines: Assessing Their Impact on Brain Tumor Clinical Practice. Assessing Their Impact on Brain Tumor Clinical Practice

  Robertson, F. C., Nahed, B. V., Barkhoudarian, G., Veeravagu, A., Berg, D., Kalkanis, S., Olson, J. J. & Germano, I. M., Jul 19 2024, In: Articles, Abstracts, and Reports. 96, 3, p. e43-e51

  Research output: Contribution to journal › Article

• Comparing Costs: Does Extreme Oncoplastic Breast-Conserving Surgery Confer a Cost Benefit When Compared with Mastectomy and Reconstruction?

  Millen, J. C., Sibia, U., Jackson, K., Stern, S. L., Orozco, J. I. J., Fancher, C. E. & Grumley, J., Oct 2024, In: Annals of Surgical Oncology. 31, 11, p. 7463-7470 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Mastectomy 100%
  • Health Care Cost 100%
  • Cost Benefit Analysis 100%
  • Quadrantectomy 100%
  • Partial Mastectomy 100%
  2 Scopus citations

• Correction: Comparing Costs: Does Extreme Oncoplastic Breast-Conserving Surgery Confer a Cost Benefit When Compared with Mastectomy and Reconstruction?(Ann Surg Oncol., 10.1245/s10434-024-15711-0)

  Millen, J. C., Sibia, U., Jackson, K., Stern, S. L., Orozco, J. I. J., Fancher, C. E. & Grumley, J., Oct 2024, In: Annals of Surgical Oncology. 31, 11, p. 7473 1 p.

  Research output: Contribution to journal › Comment/debate

  • Cost Benefit Analysis 100%
  • Partial Mastectomy 100%
  • Mastectomy 100%

• Early Experiences With Bundled Payments for Care Improvement for Major Bowel Surgery

  Sibia, U. S., Klune, J. R., Saiolghalam, S. & Bilchik, A., 2024, (Accepted/In press) In: American Surgeon.

  Research output: Contribution to journal › Article › peer-review

  • Health Care Cost 100%
  • Emergency Care 20%
  • Patient Care 20%
  • Diagnosis-Related Group 20%
  • Medicare 20%

• Genomic, immunologic, and prognostic associations of TROP2 (TACSTD2) expression in solid tumors.

  Morgenstern-Kaplan, D., Kareff, S. A., Trabolsi, A., Rodriguez, E., Krause, H., Ribeiro, J. R., Tan, H., Antonarakis, E. S., Lou, E., Nagasaka, M., Algaze, S., Lenz, H.-J., Liu, S. V., Halmos, B., Hoon, D. S. B., Seeber, A., Ma, P. C., El-Deiry, W. S., Vanderwalde, A. M. & Lopes, G., Jul 10 2024, In: Articles, Abstracts, and Reports. 29, 11, p. e1480-e1491

  Research output: Contribution to journal › Article
  1 Scopus citations

• Immunogenomics and spatial proteomic mapping highlight distinct neuro-immune architectures in melanoma vs. non-melanoma-derived brain metastasis

  Mendoza-Valderrey, A., Dettmann, E., Hanes, D., Kessler, D., Danilova, L., Rau, K., Quan, Y., Stern, S., Barkhoudarian, G., Bifulco, C., Margolin, K. A., Kolker, S. E. & Ascierto, M., May 2 2024, In: Articles, Abstracts, and Reports.

  Research output: Contribution to journal › Article

• Induced collagen type-I secretion by hepatocytes of the melanoma liver metastasis is associated with a reduction in tumour-infiltrating lymphocytes.

  Mizuno, S., Bustos, M. A., Hayashi, Y., Abe, K., Furuhashi, S., Naeini, Y., Xu, X., Bilchik, A. J. & Hoon, D. S., Nov 1 2024, In: Articles, Abstracts, and Reports.

  Research output: Contribution to journal › Article

• Multi-Cancer Early Detection Testing (MCED)

  Gordon, O. K., Bott, B., Parseghian, N., Psychogios, P., Childers, K. K. & Brown, S., Jan 1 2024

  Research output: Other contribution

  File
  10 Downloads (Pure)

• Pilot study of plasma miRNA signature panel for differentiating single vs multiglandular parathyroid disease.

  Goldfarb, M., Bustos, M. A., Moon, J., Jackson, K. M., Singer, F. R. & Hoon, D., Aug 20 2024, In: Articles, Abstracts, and Reports. 110, 3, p. 758-770 13 p.

  Research output: Contribution to journal › Article

• Population Screening for High-Risk Patient Identification Partnership with CARE-Comprehensive Assessment, Risk, and Education.

  Gordon, O. K., Bott, B., Parseghian, N., Childers, K. K. & Brown, S., Jan 1 2024

  Research output: Other contribution

  File
  10 Downloads (Pure)

• Predictors of Durable Remission After Successful Surgery for Cushing Disease: Results From the Multicenter RAPID Registry.

  Findlay, M. C., Tenhoeve, S., Alt, J., Rennert, R. C., Couldwell, W. T., Evans, J., Collopy, S., Kim, W., Delery, W., Pacione, D., Kim, A., Silverstein, J. M., Chicoine, M. R., Gardner, P., Rotman, L., Yuen, K. C. J., Barkhoudarian, G., Fernandez-Miranda, J., Benjamin, C. & Kshettry, V. R. & 5 others, Zada, G., Gompel, J. V., Catalino, M. H. S., Little, A. S. & Karsy, M., Jun 21 2024, In: Articles, Abstracts, and Reports.

  Research output: Contribution to journal › Article

• The Dance Between Tumor Molecular Biology and Antitumor Immune Response

  Margolin, K. A., Jan 17 2024, In: Clinical Cancer Research. 30, 2, p. 257-259 3 p.

  Research output: Contribution to journal › Article › peer-review

  • T Cell Receptor 100%
  • Molecular Biology 100%
  • Immune Response 100%
  • Lifespan 100%
  • Antigen Presentation 100%
  1 Scopus citations
• 2023

  AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer.

  Tolaney, S. M., Chan, A., Petrakova, K., Delaloge, S., Campone, M., Iwata, H., Peddi, P. F., Kaufman, P. A., Kermadec, E. D., Liu, Q., Cohen, P., Paux, G., Wang, L., Ternès, N., Boitier, E. & Im, S.-A., Jun 22 2023, In: Articles, Abstracts, and Reports.

  Research output: Contribution to journal › Article

  • Breast Cancer 100%
  • Monotherapy 100%
  • Gamma Urogastrone 100%
  • Epidermal Growth Factor Receptor 2 100%
  • Estrogen Receptor 100%

• A prospective multi-center observational study of surgical versus non-surgical management for pituitary apoplexy.

  Mamelak, A. N., Little, A. S., Gardner, P. A., Almeida, J. P., Recinos, P., Soni, P., Kshettry, V. R., Jane, J. A., Barkhoudarian, G., Kelly, D. F., Dodd, R., Mukherjee, D., Gersey, Z. C., Fukuhara, N., Nishioka, H., Kim, E.-H., Litré, C.-F., Sina, E., Mazer, M. W. & Cui, Y. & 1 others, Bonert, V., Sep 12 2023, In: Articles, Abstracts, and Reports.

  Research output: Contribution to journal › Article

  • Observational Study 100%
  • Hypophysis Apoplexy 100%
  • Visual Field 60%
  • Neoplasm 20%
  • Clinical Feature 20%

• Botensilimab, a novel innate/adaptive immune activator, plus balstilimab (anti-PD-1) in patients with recurrent platinum refractory/resistant ovarian cancer (041)

  Bockorny, B., O'Day, S., Margolin, K., Sanborn, R. E., Kristedja, T. S. & comments, S. A. A. I., Sep 1 2023

  Research output: Other contribution

  • Adverse Event 100%
  • Ovarian Cancer 100%
  • Diseases 100%
  • Monotherapy 50%
  • T Cell 50%

• CAN ACUPUNCTURE BE A PART OF THE TREATMENT FOR BREAST CANCER-RELATED LYMPHEDEMA? A SYSTEMATIC REVIEW OF THE SAFETY AND PROPOSED MODEL FOR CARE

  Kim, J. K., Loo, C., Kim, J. S., Pranskevich, C. & Gordon, O. K., 2023, In: Lymphology. 56, 1, p. 27-39 13 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Systematic Review 100%
  • Breast Cancer-Related Lymphedema 100%
  • Acupuncture 100%
  • Clinical Trial 44%
  • Adverse Event 33%

• Characterization of Lymph Node Metastases in Prostate Cancer. ASCO, Abst: 380, 01/2023

  Gottlieb, J., Hanes, D. A., Hoon, D. S. B. & See all authors in notes, 2023.

  Research output: Contribution to conference › Abstract

• Construction and validation of a gene expression classifier to predict immunotherapy response in primary triple-negative breast cancer.

  Ensenyat-Mendez, M., Orozco, J. I. J., Llinàs-Arias, P., Íñiguez-Muñoz, S., Baker, J. L., Salomon, M. P., Martí, M., DiNome, M. L., Cortés, J. & Marzese, D. M., Jul 10 2023, In: Articles, Abstracts, and Reports.

  Research output: Contribution to journal › Article

  • Immune Checkpoint Inhibitor 100%
  • Triple Negative Breast Cancer 100%
  • Immunotherapy 100%
  • Gene Expression 100%
  • Immune Checkpoints 100%

• Correction: Predicting Regional Lymph Node Recurrence in the Modern Age of Tumor-Positive Sentinel Node Melanoma: The Role of the First Postoperative Ultrasound (Annals of Surgical Oncology, (2022), 29, 13, (8469-8477), 10.1245/s10434-022-12345-y)

  Keller, J., Stern, S., Chang, S. C., Marcus, R., Weiss, J., Nassoiy, S., Christopher, W., Fischer, T. & Essner, R., Jun 2023, In: Annals of Surgical Oncology. 30, 6, p. 3656-3657 2 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Neoplasm 100%
  • Recurrent Disease 100%
  • Lymph Node 100%
  • Malignant Neoplasm 100%
  • Surgical Oncology 100%

• Corrigendum to "Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes" [Eur. Urol. Focus (2023)].

  Linehan, J. M., Gottlieb, J., Woldu, S. L., Labbate, C., Rose, K., Sexton, W., Kaimakliotis, H., Jacob, J., Dickstein, R., Nieder, A., Bjurlin, M., Humphreys, M., Ghodoussipour, S., Quek, M., O'Donnell, M., Eisner, B. H., Feldman, A. S., Matin, S. F., Lotan, Y. & Murray, K. S., Aug 26 2023, In: Articles, Abstracts, and Reports.

  Research output: Contribution to journal › Article

• Diagnostic cell-free miRNA Signatures Found in Plasma and Urine of Sporadic Renal Cell Carcinoma Patients

  Bustos, M., Gottlieb, J., Suyeon, R., Allen, W., Krasne, D., Wilson, T., Linehan, J. & Hoon, D., Jan 1 2023

  Research output: Other contribution

• Diagnostic Performance and Safety of Positron Emission Tomography with ¹⁸F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE)

  LIGHTHOUSE Study Group, Oct 2023, In: European Urology. 84, 4, p. 361-370 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Prostate Cancer 100%
  • Positron Emission Tomography 100%
  • Fluorine-18 100%
  • Diagnostic Performance 100%
  • Fluorine 18 100%
  49 Scopus citations

• Efficacy and Safety of Mitomycin Gel (UGN-101) as an Adjuvant Therapy After Complete Endoscopic Management of Upper Tract Urothelial Carcinoma.

  Labbate, C., Woldu, S., Murray, K., Rose, K., Sexton, W., Tachibana, I., Kaimakliotis, H., Jacob, J., Dickstein, R., Linehan, J., Nieder, A., Bjurlin, M., Humphreys, M., Ghodoussipor, S., Quek, M., O'Donnell, M., Eisner, B., Feldman, A., Lotan, Y. & Surena F, M., Jan 19 2023, In: Articles, Abstracts, and Reports.

  Research output: Contribution to journal › Article

• Evolving management of early stage pancreatic adenocarcinoma in older patients

  Nassoiy, S., Christopher, W., Marcus, R., Keller, J., Weiss, J., Chang, S. C., Essner, R., Foshag, L., Fischer, T. & Goldfarb, M., Jan 2023, In: The American Journal of Surgery. 225, 1, p. 212-219 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Pancreas Adenocarcinoma 100%
  • Adjuvant Therapy 50%
  • Health Care Quality 25%
  • Logistic Regression Analysis 25%
  • Proportional Hazards Model 25%
  5 Scopus citations

• First analysis of the safety and efficacy of UGN-101 in the treatment of ureteral tumors.

  Jacob, J. M., Woldu, S. L., Linehan, J., Labbate, C., Rose, K. M., Sexton, W. J., Tachibana, I., Kaimakliotis, H., Nieder, A., Bjurlin, M. A., Humphreys, M., Ghodoussipor, S., Quek, M. L., Johnson, B., O'Donnell, M., Eisner, B. H., Feldman, A. S., Murray, K. S., Matin, S. F. & Lotan, Y. & 1 others, Dickstein, R. J., Jul 28 2023, In: Articles, Abstracts, and Reports.

  Research output: Contribution to journal › Article

• Handgrip Strength Is Related to Hippocampal and Lobar Brain Volumes in a Cohort of Cognitively Impaired Older Adults with Confirmed Amyloid Burden

  Meysami, S., Raji, C. A., Glatt, R. M., Popa, E. S., Ganapathi, A. S., Bookheimer, T., Slyapich, C. B., Pierce, K. P., Richards, C. J., Lampa, M. G., Gill, J. M., Rapozo, M. K., Hodes, J. F., Tongson, Y. M., Wong, C. L., Kim, M., Porter, V. R., Kaiser, S. A., Panos, S. E. & Dye, R. V. & 8 others, Miller, K. J., Bookheimer, S. Y., Martin, N. A., Kesari, S., Kelly, D. F., Bramen, J. E., Siddarth, P. & Merrill, D. A., 2023, In: Journal of Alzheimer's Disease. 91, 3, p. 999-1006 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Magnetic Resonance Imaging 100%
  • Amyloid Protein 100%
  • Brain Size 100%
  • Grip Strength 100%
  • Hand Grip 100%
  14 Scopus citations

• Inhibition of Microsomal Prostaglandin E2 Synthase Reduces Collagen Deposition in Melanoma Tumors and May Improve Immunotherapy Efficacy by Reducing T-cell Exhaustion

  Fukuda, Y., Kim, S.-H., Bustos, M. A., Cho, S.-N., Roszik, J., Burks, J. K., Kim, H., Hoon, D. S. B., Grimm, E. A. & Ekmekcioglu, S., Jun 2023, In: Cancer research communications. 3, 7, p. 1397-1408 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Synthase 100%
  • T Cell 100%
  • Prostaglandin E2 100%
  • Cyclooxygenase 33%
  • Tumor Immunity 20%
  3 Scopus citations

• Lucchesi O, Ruete MC, Mayorga LS, and Tomes CN

  Bustos, M., Jan 1 2023

  Research output: Other contribution

• Mechanism-Driven and Clinically Focused Development of Botanical Foods as Multitarget Anticancer Medicine: Collective Perspectives and Insights from Preclinical Studies, IND Applications and Early-Phase Clinical Trials

  Wang, X., Chan, Y. S., Wong, K., Yoshitake, R., Sadava, D., Synold, T. W., Frankel, P., Twardowski, P. W., Lau, C. & Chen, S., Feb 2023, In: Cancers. 15, 3, 701.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Medicine 100%
  • Clinical Trial 100%
  • Preclinical Study 100%
  • Malignant Neoplasm 66%
  • Clinical Study 50%
  8 Scopus citations

• Mitomycin Gel (UGN-101) as a Kidney-sparing Treatment for Upper Tract Urothelial Carcinoma in Patients with Imperative Indications and High-grade Disease.

  Kyle M, R., Katie S, M., Labbate, C., Woldu, S., Linehan, J., Jacob, J., Kaimakliotis, H., Dickstein, R., Feldman, A., Surena F, M., Lotan, Y., Mitchell R, H. & Wade J, S., Apr 12 2023, In: Articles, Abstracts, and Reports.

  Research output: Contribution to journal › Article

• Monitoring 1q21.3 amplification in circulating tumor DNA from metastatic melanoma patients receiving immune checkpoint inhibitor therapies

  Hoon, D., Lin, S., Kobayashi, Y., Zhang, X., Yu, Q., O’Day, S. & Bustos, M., Jan 1 2023

  Research output: Other contribution

• Multi-omic characterization of RCC1 expression and its association with molecular alterations, immune phenotypes, and cancer outcomes. ASCO, Abst:3128, 6/2023.

  Warnecke, B., Hoon, D. & comments, S. F. L. O. A. I., Jun 1 2023

  Research output: Other contribution

• Pan-cancer associations of B7-H3 (CD276) transcriptioinal expression across human malignancies. ASCO, Abst:2624, 6/2023.

  Hwang, J., Hoon, D. & comments, S. F. L. O. A. I., Jun 1 2023

  Research output: Other contribution

• Patient Perception of Education, Care Coordination, and Psychological Distress After Developing Facial Paralysis: A Qualitative Study.

  Natalie R, K., Estafanous, M., Itamura, K., Filus, A., Gowrinathan, S., Neil A, M., Sivakumar, W., Barkhoudarian, G., Patrick J, B. & Kochhar, A., Apr 20 2023, In: Articles, Abstracts, and Reports.

  Research output: Contribution to journal › Article

• Peripheral and tissue persistence of agenT-797, an allogeneic iNKT cell-based cell therapy for the treatment of cancer

  Moon, J., Sanborn, R., Hoon, D. & comments, S. F. L. O. A. I., Nov 1 2023

  Research output: Other contribution

• Persistent Multispecies Actinomyces Mastitis Treated With Repeated Aspiration and Long-Term Oral Antibiotics

  Jenkins, C., Ganapathy, A., Fancher, C. & Matsushima, K., May 2023, In: American Surgeon. 89, 5, p. 2076-2078 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Mastitis 100%
  • Actinomyces 100%
  • Breast Abscess 100%
  • Antibiotics 100%
  • Infection 66%
  1 Scopus citations

• Phase 1 clinical update of allogeneic invariant natural killer T cells (iNKTs), agenT-797, alone or in combination with pembrolizumab or nivolumab in patients with advanced solid tumors. #CT275: AACR ProcVol 83; (8_Supplement): CT275. AACR meeting Orlando, FL, 2023.

  Carneiro, B., Sanborn, R., Hoon, D. S. B. & See all authors in notes, 2023.

  Research output: Contribution to conference › Abstract

• Results from a phase 1a/1b study of botensilimab (BOT), a novel innate/adaptive immune activator, plus balstilimab (BAL; anti-PD-1 antibody) in metastatic heavily pretreated microsatellite stable colorectal cancer (MSS CRC).

  El-Khoueiry, A. B., Margolin, K. A., Sanborn, R. E. & comments, S. A. A. I., Jan 1 2023

  Research output: Other contribution

  • Overall Survival 100%
  • T Cell 100%
  • Colitis 100%
  • Adverse Event 100%
  • Colorectal Carcinoma 100%

• Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes.

  Linehan, J. M., Gottlieb, J., Woldu, S. L., Labbate, C., Rose, K., Sexton, W., Kaimakliotis, H., Jacob, J., Dickstein, R., Nieder, A., Bjurlin, M., Humphreys, M., Ghodoussipor, S., Quek, M., O'Donnell, M., Eisner, B. H., Feldman, A. S., Matin, S. F., Lotan, Y. & Murray, K. S., May 30 2023, In: Articles, Abstracts, and Reports.

  Research output: Contribution to journal › Article

  • Transitional Cell Carcinoma 100%
  • Route of Administration 100%
  • Bladder 66%
  • Ureter 66%
  • Ureter Stricture 66%

• Safety and Efficacy Outcomes From a Single-Center Study of Image-Guided Percutaneous Microwave Ablation for Primary and Metastatic Lung Malignancy.

  Stephen M, C., Peter J, J., Kaganjo, P., McKenna, R., Forscher, C., Natale, R., Robert N, W., Butenschoen, K., Rene J, S. & Mirocha, J., Feb 1 2023, In: Articles, Abstracts, and Reports.

  Research output: Contribution to journal › Article

• The 16th International Congress of the Society for Melanoma Research (SMR), November 20-23, 2019

  Bustos, M., Jan 1 2023

  Research output: Other contribution

• The 31-gene expression profile test informs sentinel lymph node biopsy decisions in patients with cutaneous melanoma: results of a prospective, multicenter study

  Yamamoto, M., Sickle-Santanello, B., Beard, T., Essner, R., Martin, B., Bailey, C. N. & Guenther, J. M., 2023, In: Current Medical Research and Opinion. 39, 3, p. 417-423 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Gene Expression 100%
  • Sentinel Lymph Node Biopsy 100%
  • Melanoma Skin Cancer 100%
  • Cutaneous Melanoma 100%
  • Clinician 21%
  12 Scopus citations

• The ablative effect of mitomycin reverse thermal gel: Expanding the role for nephron preservation therapy in low grade upper tract urothelial carcinoma.

  Kaimakliotis, H. Z., Tachibana, I., Woldu, S., Labbate, C., Jacob, J., Murray, K., Rose, K., Sexton, W., Dickstein, R., Linehan, J. M., Nieder, A., Bjurlin, M., Humphreys, M., Ghodoussipor, S., Quek, M., O'Donnell, M., Eisner, B. H., Matin, S. F., Lotan, Y. & Feldman, A. S., May 26 2023, In: Articles, Abstracts, and Reports.

  Research output: Contribution to journal › Article

  • Nephron 100%
  • Transitional Cell Carcinoma 100%
  • Mitomycin 100%
  • Diseases 100%
  • Neoplasm 37%

• Transcriptomic signatures in melanoma lymph node metastasis that relate to immune oncology treatment. #6375. AACR Proc, Vol 83; AACR meeting Orlando, FL, 2023.

  Bustos, M., Hoon, D. S. B. & See all authors in notes, 2023.

  Research output: Contribution to conference › Abstract

• Treatment of Cushing Disease With Pituitary-Targeting Seliciclib

  Liu, N. A., Ben-Shlomo, A., Carmichael, J. D., Wang, C., Swerdloff, R. S., Heaney, A. P., Barkhoudarian, G., Kelly, D., Noureddin, M., Lu, L., Desai, M., Stolyarov, Y., Yuen, K., Mamelak, A. N., Mirocha, J., Tighiouart, M. & Melmed, S., Mar 1 2023, In: Journal of Clinical Endocrinology and Metabolism. 108, 3, p. 726-735 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Roscovitine 100%
  • Hydrocortisone 100%
  • Cushing Disease 100%
  • Corticotropin 25%
  • Preclinical Study 12%
  21 Scopus citations